SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
April
18, 2005
Date of
Report
(Date of
earliest event reported)
RITA
Medical Systems, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State or
other jurisdiction of incorporation)
000-30959 |
94-3199149 |
(Commission
File Number) |
(I.R.S.
Employer Identification No.) |
967
N. Shoreline Blvd.
Mountain
View, CA 94043
(Address
of principal executive offices, with zip code)
(650)
314-3400
(Registrant's
telephone number, including area code)
Item
1.01. Entry
into a Material Definitive Agreement.
On April
18, 2005, the Board of Directors of RITA Medical Systems, Inc., a Delaware
corporation (the “Company”),
granted options to purchase shares of the Company's common stock to its
non-employee directors under the 2000 Stock Plan. The Company's Audit Committee
approved such grants. Vincent Bucci received one option grant to purchase 20,000
shares of the Company's common stock in recognition of his services as Chairman
of the Board during fiscal 2004, and James E. Brands, Vincent Bucci, Thomas J.
Dugan, Scott Halsted, Wesley E. Johnson, Jr., Randy Lindholm and Robert Tucker
each received one option grant for 5,000 shares of the Company's common stock in
recognition of their services on one or more committees of the Board of
Directors during fiscal 2004. All such options have an exercise price of $3.07,
the closing price of the Company's common stock on April 18, 2005, and are fully
vested and immediately exercisable.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
RITA Medical
Systems, Inc. |
|
|
|
| Date: April 20, 2005 |
By: |
|
|
/s/ Donald Stewart
Donald Stewart, Chief Financial Officer and |
| |
Vice President Finance and
Administration |